MSB 6.07% $1.01 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-407

  1. 1,653 Posts.
    lightbulb Created with Sketch. 210
    There was this announcement on publication by the BBMT.

    3 Articles on RYONCIL GvHD Trial Results Published in BBMT

    25 05 2020 10:52am AEST

    Progress Report -MSB
    Read full story
    What


    Last edited by What: 10/08/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.